Pharsight

Teva Pharms patents expiration

1. Vandazole patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7456207 TEVA PHARMS Vaginal pharmaceutical compositions and methods for preparing them
Sep, 2024

(4 months from now)

Drugs and Companies using METRONIDAZOLE ingredient

Market Authorisation Date: 20 May, 2005

Treatment: NA

Dosage: GEL;VAGINAL

More Information on Dosage

VANDAZOLE family patents

Family Patents